Status: current, Sufficiently defined by necessary conditions definition status. Date: 30-Apr 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5035512019 | SARS-CoV-2 breakthrough infection | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 5035513012 | COVID-19 breakthrough infection | en | Synonym | Active | Entire term case sensitive | SNOMED CT core module |
| 5035515017 | Severe acute respiratory syndrome coronavirus 2 breakthrough infection | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5035516016 | Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 (disorder) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 5035517013 | Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | Is a | Infection following immunization | true | Inferred relationship | Existential restriction modifier | ||
| Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | Is a | Disease caused by severe acute respiratory syndrome coronavirus 2 | true | Inferred relationship | Existential restriction modifier | ||
| Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | After | Administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | true | Inferred relationship | Existential restriction modifier | 2 | |
| Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | Pathological process | Infectious process | true | Inferred relationship | Existential restriction modifier | 1 | |
| Disease caused by severe acute respiratory syndrome coronavirus 2 following administration of vaccine product against severe acute respiratory syndrome coronavirus 2 | Causative agent | Severe acute respiratory syndrome coronavirus 2 | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR